IP Library › Granted Patent US 12,291,748
Granted Patent B2
US 12,291,748 · App. 16/987,092 · Granted May 6, 2025

Acridinium ester-containing compounds and methods of using the same for chemiluminescence-based one-color sequencing

Inventors: Yan Chen (Sunnyvale, CA); Handong Li (San Jose, CA)
Assignee: MGI Holdings Co., Limited
C12Q1/6874C07D401/12G01N21/76
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,291,748
App. No.
16/987,092
Granted
May 6, 2025
Kind
B2
Abstract

Acridinium ester-containing compounds are provided herein. Also provided herein are chemiluminescence-based one-color sequencing methods and methods of using the acridinium ester-containing compounds in chemiluminescence-based one-color sequencing.

Claims (27)

1. A compound including a nucleotide moiety of the following formula:

wherein:

R 1 is a linking group comprising a C 1 -C 8 alkyl sulfonyl piperidine;

R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen, —CH 3 , —OCH 3 , substituted or unsubstituted C 1-8 alkyl, substituted or unsubstituted C 2-8 alkenyl, and substituted or unsubstituted C 2-8 alkynyl, wherein the substituted alkyl group or the substituted alkenyl group is independently substituted with one or more members selected from the group consisting of a hydroxyl, a halogen, and a carboxyl group;

R 7 is a nucleotide moiety of the following formula:

 wherein

R 8 is the nitrogenous base, which is a member selected from the group consisting of:

 and

R 9 is hydrogen or a blocking group; and

X − is a counteranion.

2. The compound of claim 1 , wherein R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen and substituted or unsubstituted C 1-6 alkyl.

3. The compound of claim 1 , wherein R 4 , R 5 , and R 6 are each independently selected from hydrogen and methyl.

4. The compound of claim 1 , wherein R 4 is methyl, R 5 is methyl, and R 6 is hydrogen.

5. The compound of claim 1 , wherein each of R 4 , R 5 , and R 6 is hydrogen.

6. The compound of claim 1 , wherein R 7 is the nucleotide moiety and R 8 is the nitrogenous base selected from the group consisting of:

7. The compound of claim 1 , wherein R 9 is the blocking group, wherein the blocking group is selected from the group consisting of —CH 2 N 3 , —NH 2 ,—CH 2 CH—CH 2 ,—CH 2 OCH 3 , polyethylene glycol, and a substituted or unsubstituted alkyl.

8. A nucleotide moiety for one-color sequencing having the following formula:

wherein:

R 1 is a linking group comprising a C 1 -C 8 alkyl sulfonyl piperidine;

R 4 , R 5 , and R 6 are each independently selected from the group consisting of hydrogen, —CH 3 and OCH 3 ;

R 7 is a nucleotide moiety of the following formula:

 wherein

R 8 is the nitrogenous base, which is a member selected from the group consisting of:

 and

R 9 is hydrogen or a blocking group; and

X − is a counteranion.

9. The compound of claim 8 , wherein the compound is a member selected from the group consisting of:

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2022
From: BGI SHENZHEN CO., LTD.
To: MGI HOLDINGS CO., LIMITED
Reel/Frame 061090/0915 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2021
From: BGI RESEARCH USA, INC.
To: BGI SHENZHEN CO., LTD.
Reel/Frame 056349/0779 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 29, 2020
From: CHEN, YAN; LI, HANDONG
To: BGI RESEARCH USA INC.
Reel/Frame 054217/0075 →
Continuity (2)
Provisional Application 62883760 · Aug 7, 2019
Related Publication 20210040556A1 · Feb 11, 2021
References Cited (29)
US 6018047A · Zomer · 2000 [cited by examiner]
US 9222132B2 · Drmanac · 2015 [cited by applicant]
US 20050147965A1 · Zhong et al. · 2005 [cited by applicant]
US 20070166759A1 · Weeks · 2007 [cited by examiner]
US 20090263802A1 · Drmanac · 2009 [cited by applicant]
US 20180223358A1 · Drmanac et al. · 2018 [cited by applicant]
US 20180346980A1 · Drmanac · 2018 [cited by applicant]
EP 0324202A1 · 1989 [cited by applicant]
EP 0609885A1 · 1994 [cited by applicant]
JP 2012020958A · 2012 [cited by applicant]
WO 0109372A1 · 2001 [cited by applicant]
WO 2004018418A2 · 2004 [cited by applicant]
WO 2005065350A2 · 2005 [cited by applicant]
WO 2009097368A2 · 2009 [cited by applicant]
WO 2018165207A1 · 2018 [cited by applicant]
Guo et al. (Account of Chemical Research, vol. 43, No. 4, Apr. 2010, p. 551-563) (Year: 2010). [cited by examiner]
Natrajan et al., Org. Biomol. Chem., 2013, 11, 1026-1039. DOI: https://doi.org/10.1039/C2OB27190G (Year: 2013). [cited by examiner]
International Application No. PCT/CN2020/107298, International Preliminary Report on Patentability mailed on Feb. 17, 2022, 6 pages. [cited by applicant]
Blackburn et al., “Management of Incidental Findings in the Era of Next-generation Sequencing”, Curr. Genomics, 2015, pp. 159-174, vol. 16, No. 3. [cited by applicant]
Stranneheim et al., “Stepping stones in DNA sequencing”, Biotechnol. J., Aug. 8, 2012, pp. 1063-1073, vol. 7, Issue 9. [cited by applicant]
Guo et al., “An Integrated System for DNA Sequencing by Synthesis Using Novel Nucleotide Analogues”, Acc. Chem. Res., Feb. 3, 2010, pp. 551-563, 43, 4. [cited by applicant]
Mardis, “Next-Generation Sequencing Platforms”, Annu. Rev. Anal. Chem., Jun. 2013, pp. 287-303, vol. 6. [cited by applicant]
Metzker, “Sequencing technologies—the next generation”, Nat. Rev. Genet., Dec. 8, 2009, pp. 31-46, 11. [cited by applicant]
Goodwin et al., “Coming of age: ten years of next-generation sequencing technologies”, Nat. Rev. Genet., May 17, 2016, pp. 333-351, 17. [cited by applicant]
Application PCT/CN2020/107298, International Search Report and Written Opinion, Nov. 10, 2020, 9 pages. [cited by applicant]
Application No. CN202080056098.6 , Office Action, Mailed on Apr. 4, 2023, 8 pages, Translation begins on p. 7. [cited by applicant]
European Application No. EP20849079.7, Partial Supplementary European Search Report mailed on Sep. 29, 2023, 14 pages. [cited by applicant]
Holec-Gasior et al., A Novel Chemiluminescent Immunoassay for Detection of Toxoplasma Gondii IgG in Human Sera, Diagnostic Microbiology and Infectious, vol. 85, No. 4, May 2016, pp. 422-425. [cited by applicant]
European Application No. 20849079.7, Extended European Search Report mailed on Jan. 10, 2024, 12 pages. [cited by applicant]